Page last updated: 2024-11-02

perhexiline and Fatty Liver, Nonalcoholic

perhexiline has been researched along with Fatty Liver, Nonalcoholic in 2 studies

Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

Research Excerpts

ExcerptRelevanceReference
"Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of macrovesicular steatosis, cellular ballooning, and inflammation."2.48A myriad of pathways to NASH. ( Larrain, S; Rinella, ME, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, ZJ1
Fu, Q1
Ma, C1
Kruhlak, M1
Zhang, H1
Luo, J1
Heinrich, B1
Yu, SJ1
Zhang, Q1
Wilson, A1
Shi, ZD1
Swenson, R1
Greten, TF1
Larrain, S1
Rinella, ME1

Reviews

1 review available for perhexiline and Fatty Liver, Nonalcoholic

ArticleYear
A myriad of pathways to NASH.
    Clinics in liver disease, 2012, Volume: 16, Issue:3

    Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Disea

2012

Other Studies

1 other study available for perhexiline and Fatty Liver, Nonalcoholic

ArticleYear
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4
    Cell death & disease, 2018, 05-23, Volume: 9, Issue:6

    Topics: 3T3 Cells; Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Carnitine O-Palmitoyltrans

2018